ADIPOQ and Alzheimer disease: The same results were obtained in previous studies showing an association of higher circulating (or cerebrospinal fluid) adiponectin level with increased risk of AD (Une et al. 2011; van Himbergen et al. 2012; Khemka et al. 2014).